Emerson Electric Co. (EMR) is a global industrial technology and automation company, not an ETF, so this analysis rests on individual analyst price targets. Reviewing 11 current, attributable targets, the mean is about $152, with a range from roughly $135 (Barclays, Equal-Weight) to $170 (Evercore ISI, Outperform, initiated in December 2025). Other notable targets include Citigroup at $165 (Buy), Deutsche Bank at $159 (Buy), KeyBanc at $155, RBC Capital at $153 (Outperform), J.P. Morgan at $150 (Neutral), Jefferies at $145 (Hold, downgraded from Buy), and Wells Fargo at $140 (Equal-Weight, downgraded from Overweight).
Because that mean of roughly $152 is only about 6% above the latest verified price near $143 — too close to serve as a meaningful objective under the methodology used here — the $165 central target reflects the more constructive band of publicly circulated price objectives, anchored by Citigroup's $165 and Evercore ISI's $170, and is presented as a public-discussion objective rather than an analyst consensus. Street sentiment is broadly "Moderate Buy," though the wide $135-to-$170 spread shows genuine disagreement about how much of Emerson's growth is already priced in.
Emerson's shares have been volatile, trading in a range of roughly $123 to $144 over the late-2025 period after its fiscal fourth-quarter report. With the latest verified price near $143, a move to $165 implies about 15% upside — a modest-to-substantial advance that would require the stock to clear its recent highs and sustain positive momentum. The company closed fiscal 2025 (ended September 30, 2025) with revenue of roughly $17.5 billion, adjusted EPS (earnings per share) of $6.00, up 9% year over year, and free cash flow of $3.24 billion, up 12%.
For fiscal 2026, management guides to sales growth of about 5.5% (about 4% underlying) and adjusted EPS of $6.35 to $6.55, supported by a $7.4 billion backlog and an $11.1 billion project funnel, roughly $6 billion of which is tied to secular-driven verticals. Reaching $165 would likely require the market to reward this earnings trajectory with sustained valuation support near current multiples.
Several verified factors favor a higher price. Emerson's portfolio is aligned with long-cycle demand in LNG (liquefied natural gas), power generation, data centers and AI infrastructure, semiconductors, and life sciences. Management has reported mid-single-digit underlying orders growth for three consecutive quarters. The company is also pivoting toward shareholder returns: it plans to return about $2.2 billion in fiscal 2026 through roughly $1 billion of buybacks and $1.2 billion of dividends, while raising its dividend 5% — marking its 70th consecutive year of increases. Analysts citing upside, including Citigroup and Evercore ISI, point to these secular tailwinds, recurring software revenue from the AspenTech platform, and margin expansion as reasons for higher targets.
Valuation is the principal obstacle. Emerson has traded near a P/E (price-to-earnings) ratio of roughly 28 times, which leaves limited room for multiple expansion if growth disappoints. Europe and China demand have been soft, and tariffs and project-timing shifts create execution risk. Management also flagged a software contract-renewal headwind of roughly $110 million in the first half of fiscal 2026, and its first-quarter adjusted EPS guidance of about $1.40 came in below some Street estimates. If orders, margin delivery, or acquisition synergies fall short, the stock could struggle to justify a move toward $165.
Emerson's shares dipped sharply after its November 2025 earnings report before recovering toward the $143 area by mid-December. The recent $123-to-$144 range suggests that $144 marks a near-term ceiling that would need to be broken, with $150 and $160 acting as round-number psychological levels on the way to $165. A sustained close above the prior December highs would be a constructive signal, while a retreat below the low-$130s could call the recovery into question.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms vary. The most relevant upcoming catalysts are Emerson's quarterly earnings and guidance, the pace of orders and backlog conversion, progress on margin expansion and AspenTech synergies, capital-spending trends in energy and data centers, and any analyst target revisions. Investors should also watch macroeconomic data, Federal Reserve rate decisions, and tariff or trade-policy developments that could affect global industrial demand.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. For a volatile industrial name like Emerson, these signals can help traders spot changing trends, monitor positions, and identify opportunities more efficiently than manual screening. Traders can use the tool to complement their own research and respond to evolving momentum.
The $165 target is a public-discussion objective anchored to the more constructive end of analyst coverage, not a formal consensus, and it requires roughly 15% upside from the latest verified price near $143. The path is supported by secular energy and data-center demand, margin expansion, and rising capital returns, but it is challenged by a rich valuation, regional softness, and execution risk. With analyst targets spanning roughly $135 to $170, the debate is less about Emerson's business quality than about how much of its growth is already reflected in the share price. Whether EMR can reach $165 will likely hinge on sustained order momentum and margin delivery in the quarters ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, EMR has been closely correlated with AME. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then AME could also see price increases.
| Ticker / NAME | Correlation To EMR | 1D Price Change % |
|---|---|---|
| EMR | 100% | +0.45% |
| EMR (5 stocks) | 82% Closely correlated | +0.82% |
| Producer Manufacturing (350 stocks) | 14% Poorly correlated | -0.40% |